Details for Patent: 8,003,681
Summary for Patent: 8,003,681
| Title: | 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl ester |
| Abstract: | A series of S-triazolyl α-mercaptoacetanilides having general structure (1) are provided, where Q is CO2H, CONR2, SO3H, or SO2NR2. The compounds inhibit several variants of the reverse transcriptase of HIV, and are useful in the treatment of HIV infections. |
| Inventor(s): | Jean-Luc Girardet, Yung-hyo Koh |
| Assignee: | Ardea Biociences Inc |
| Application Number: | US12/633,638 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 8,003,681
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,003,681
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2135608 | ⤷ Start Trial | 300825 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2135608 | ⤷ Start Trial | PA2016024 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2135608 | ⤷ Start Trial | 93169 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2135608 | ⤷ Start Trial | CA 2016 00034 | Denmark | ⤷ Start Trial |
| European Patent Office | 2135608 | ⤷ Start Trial | CR 2016 00034 | Denmark | ⤷ Start Trial |
| European Patent Office | 2135608 | ⤷ Start Trial | 16C0031 | France | ⤷ Start Trial |
| European Patent Office | 2135608 | ⤷ Start Trial | 122016000060 | Germany | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
